Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 16, Number 6—June 2010

Enterovirus Genotype EV-104 in Humans, Italy, 2008–2009

Antonio Piralla, Francesca Rovida, Fausto Baldanti, and Giuseppe GernaComments to Author 
Author affiliations: Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico Policlinico, San Matteo, Pavia, Italy

Main Article


Characteristics of 5 patients with HEV genotype EV-104 infection, Pavia, Italy, 2009*

Patient no. Sample no. Age, y/sex Hospital department, date of admission Respiratory secretion Ct value
Clinical symptoms Underlying disease Virus identified/ coinfecting virus (Ct)
Pav-1 NPA/9210 60/M Hematology outpatient, Apr 29.67 Undetected Fever, cough, rhinorrhea HSCT (AML) EV-104
Pav-2 NPA/9570 62/M Infectious Diseases outpatient, Apr 23.06 23.05 Chronic rhinopharyngitis None EV-104
Pav-3 NPA/11228 7/F Pediatric Oncohematology, May 33.64 Undetected Fever, rhinorrhea, conjunctivitis AML (chemotherapy) EV-104
Pav-4 NPA/11230 37/F Infectious Diseases outpatient, May 32.60 Undetected Chronic rhinopharyngitis None EV-104
Pav-5 NPA/13174 2/M Pediatric Oncohematology, Jun 23.78 31.61 Cough, rhinorrhea, diarrhea, wheezing HSCT (AML) EV-104/RSV (18.53)

*HEV, human enterovirus; Ct, cycle threshold; HRV, human rhinovirus; NPA, nasopharyngeal aspirate; HSCT, hematopoietic stem cell transplant; AML, acute myelocytic leukemia; RSV, respiratory syncytial virus.

Main Article

Page created: February 10, 2011
Page updated: February 10, 2011
Page reviewed: February 10, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.